TrialActa paediatrica (Oslo, Norway : 1992)2019

No neurodevelopmental benefit of cerebral oximetry in the first randomised trial (SafeBoosC II) in preterm infants during the first days of life.

Anne M Plomgaard et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.